<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39446607</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1537-2995</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>24</Day></PubDate></JournalIssue><Title>Transfusion</Title><ISOAbbreviation>Transfusion</ISOAbbreviation></Journal><ArticleTitle>Shared decision-making for patients with vaccine-related concerns of blood transfusion: A single institution experience.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1111/trf.18052</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Some patients express concerns regarding receipt of allogeneic blood transfusions from donors potentially vaccinated against SARS-CoV-2 (COVID-19). However, limited information exists about patients' expression of these concerns or how to address them during the blood transfusion consent process. In this study, we describe our experience of working collaboratively with patients with vaccine-related transfusion concerns prior to elective surgery, summarizing treatment decisions and clinical outcomes.</AbstractText><AbstractText Label="STUDY DESIGN AND METHODS" NlmCategory="METHODS">This observational descriptive study includes patients seen in our Bloodless Medicine and Surgery clinic between June 2022 and June 2024 for vaccine-related transfusion concerns prior to elective surgery. A shared decision-making framework was employed to foster conversation, share information, provide reassurance, reconcile conflict, and match preferences with available care options. Patient characteristics, treatment decisions, and surgical outcomes were reviewed and summarized.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Thirty-five patients were included, with median (1st, 3rd quartile) age of 61 (53, 69) years. Cardiac surgery was the most common type of surgery (29%). Twelve patients (34%) were anemic preoperatively, and all received preoperative treatment. After discussion with a Bloodless Medicine specialist, 24 (68.6%) decided to consent to the use of all blood products, 5 (14.3%) accepted only red blood cells, and 6 (17.1%) declined all blood products. Among 28 patients undergoing surgery, only 4 (14%) received allogeneic transfusion perioperatively.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Many patients concerned about the vaccination status of blood donors may ultimately consent to allogeneic blood products after shared decision-making with a Bloodless Medicine specialist, highlighting the importance of patient empowerment and collaborative care.</AbstractText><CopyrightInformation>© 2024 AABB.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>David J</ForeName><Initials>DJ</Initials><Identifier Source="ORCID">0000-0002-1351-4313</Identifier><AffiliationInfo><Affiliation>Mayo Clinic Alix School of Medicine, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klompas</LastName><ForeName>Allan M</ForeName><Initials>AM</Initials><Identifier Source="ORCID">0000-0001-8852-4666</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Patient Blood Management Program, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonzalez</LastName><ForeName>Jessica A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Patient Blood Management Program, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petsch</LastName><ForeName>Jamie L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Patient Blood Management Program, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burt</LastName><ForeName>Jen M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Patient Blood Management Program, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kor</LastName><ForeName>Daryl J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Patient Blood Management Program, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Winters</LastName><ForeName>Jeffrey L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Division of Transfusion Medicine, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Buskirk</LastName><ForeName>Camille M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Division of Transfusion Medicine, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Warner</LastName><ForeName>Matthew A</ForeName><Initials>MA</Initials><Identifier Source="ORCID">0000-0002-6625-8755</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Patient Blood Management Program, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K23HL153310</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><Agency>National Institutes of Health (NIH)</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Transfusion</MedlineTA><NlmUniqueID>0417360</NlmUniqueID><ISSNLinking>0041-1132</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">RBC transfusion</Keyword><Keyword MajorTopicYN="N">consent</Keyword><Keyword MajorTopicYN="N">donors</Keyword><Keyword MajorTopicYN="N">patient blood management</Keyword><Keyword MajorTopicYN="N">platelet transfusion</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>7</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>7</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>24</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39446607</ArticleId><ArticleId IdType="doi">10.1111/trf.18052</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Jacobs JW, Bibb LA, Savani BN, Booth GS. Refusing blood transfusions from COVID‐19‐vaccinated donors: are we repeating history? Br J Haematol. 2022;196:585–588.</Citation></Reference><Reference><Citation>Forkin KT, Guinn NR, Warner MA, Panigrahi AK. Addressing patient concerns with blood transfusion from donors vaccinated against COVID‐19: a clinician primer. Anesthesiology. 2024;140:1020–1025.</Citation></Reference><Reference><Citation>Important information about directed blood donations that are not medically indicated [monograph on the internet]. U.S. Food and Drug Administration. 2023. Available from: https://www.fda.gov/vaccines‐blood‐biologics/safety‐availability‐biologics/important‐information‐about‐directed‐blood‐donations‐are‐not‐medically‐indicated</Citation></Reference><Reference><Citation>Regulatory update: FDA clarifies blood labeling requirements related to COVID‐19 vaccination of donors [monograph on the internet]. Association for the Advancement of Blood &amp; Biotherapies. 2024. Available from: https://www.aabb.org/news‐resources/news/article/2024/02/28/regulatory‐update‐fda‐clarifies‐blood‐labeling‐requirements‐related‐to‐covid‐19‐vaccination‐of‐donors</Citation></Reference><Reference><Citation>Roubinian NH, Greene J, Liu VX, Lee C, Mark DG, Vinson DR, et al. Clinical outcomes in hospitalized plasma and platelet transfusion recipients prior to and following widespread blood donor SARS‐CoV‐2 infection and vaccination. Transfusion. 2024;64:53–67.</Citation></Reference><Reference><Citation>What to know about the coronavirus and blood donation [monograph on the internet]. The American National Red Cross. 2024. Available from: https://www.redcrossblood.org/donate‐blood/dlp/coronavirus‐covid‐19‐and‐blood‐donation.html</Citation></Reference><Reference><Citation>Montori VM, Ruissen MM, Hargraves IG, Brito JP, Kunneman M. Shared decision‐making as a method of care. BMJ Evid Based Med. 2023;28:213–217.</Citation></Reference><Reference><Citation>Jones JM, Manrique IM, Stone MS, Grebe E, Saa P, Germanio CD, et al. Estimates of SARS‐CoV‐2 seroprevalence and incidence of primary SARS‐CoV‐2 infections among blood donors, by COVID‐19 vaccination status – United States, April 2021‐September 2022. MMWR Morb Mortal Wkly Rep. 2023;72:601–605.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>